Optimi
← optimi.net

Press releases.

Page 7 of 8

012022
022021

  • Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department

    Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness sector, is pleased to announce a facility inspection under the…

  • Optimi Health Requests Final Inspection for Dealer's License

    Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness sector, is pleased to announce it has substantially completed…

  • Optimi Health Engages Expert Management Consultancy to Drive Corporate Visibility

    Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness sector, is pleased to announce the engagement of management an…

  • Optimi Health Appoints Principal Investigator for Clinical Dosing Study

    Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness sector, is pleased to announce the appointment of Valerie H. T…

  • Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application

    Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to advise of a recent patent filing pertaining to a breakthrough process that facilitates th…

  • Optimi Health Updates Build-Out of Mushroom Production and Research Facility

    Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to offer an activity update at its 20,000 sq. ft. production and research facility in Prince…

  • Optimi Health Appoints New Chief Executive Officer

    Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that William (Bill) J. Ciprick has been appointed as the Company's Chief Executi…

  • Optimi Health Updates Launch of Online Functional Mushroom Sales

    Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, announced today that preparations for a fourth quarter launch of online sales featuring a full lineup of…

  • Optimi Health Strengthens Clinical and Regulatory Expertise

    Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), as part of its strategic aim to fully investigate the science of mushrooms, is pleased to announce the engagement of industry veteran Mr. John Simon to facilitate regulatory submissions and planning relevant to k…